MYLAN MS ADVOCATE Trademark

Trademark Overview

On Friday, April 17, 2015, a trademark application was filed for MYLAN MS ADVOCATE with the United States Patent and Trademark Office. The USPTO has given the MYLAN MS ADVOCATE trademark a serial number of 86600810. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, June 21, 2024. This trademark is owned by Mylan Inc.. The MYLAN MS ADVOCATE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing information to patients relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals for the treatment of multiple sclerosis
mylan ms advocate

General Information

Serial Number86600810
Word MarkMYLAN MS ADVOCATE
Filing DateFriday, April 17, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, June 21, 2024
Registration Number5350978
Registration DateTuesday, December 5, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 9, 2016

Trademark Statements

Description of MarkThe mark consists of the word "MYLAN" in blue and the letters "MS" in orange and the word "ADVOCATE" in blue under "MYLAN MS" with a depiction of a person's head and arms appearing in the "O" in "ADVOCATE" wherein the head is blue and the arms are orange. The white appearing in the drawing represents transparent areas and is not a feature of the mark.
Pseudo MarkMYLAN MULTIPLE SCLEROSIS ADVOCATE
Indication of Colors claimedThe color(s) blue and orange is/are claimed as a feature of the mark.
Goods and ServicesProviding information to patients relating to diagnostic, prophylactic, and therapeutic properties of pharmaceuticals for the treatment of multiple sclerosis
NOT AVAILABLE"MS"

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, June 21, 2024
Primary Code044
First Use Anywhere DateThursday, October 5, 2017
First Use In Commerce DateThursday, October 5, 2017

Trademark Owner History

Party NameMYLAN PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressMorgantown, WV 26505
Party NameMylan Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMylan Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317
Party NameMylan Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCanonsburg, PA 15317

Trademark Events

Event DateEvent Description
Thursday, June 25, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 21, 2015NEW APPLICATION ENTERED
Monday, April 27, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 28, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, June 21, 2015ASSIGNED TO EXAMINER
Thursday, June 25, 2015NON-FINAL ACTION WRITTEN
Thursday, June 25, 2015NON-FINAL ACTION E-MAILED
Thursday, December 17, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 1, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 11, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 11, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, December 12, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 17, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 18, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 17, 2015NON-FINAL ACTION WRITTEN
Thursday, December 17, 2015NON-FINAL ACTION E-MAILED
Thursday, December 17, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2017SOU EXTENSION 2 FILED
Wednesday, January 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 9, 2016PUBLISHED FOR OPPOSITION
Tuesday, February 9, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 5, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, September 28, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, September 28, 2016SOU EXTENSION 1 FILED
Wednesday, September 28, 2016SOU EXTENSION 1 GRANTED
Friday, September 30, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, March 22, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, March 22, 2017SOU EXTENSION 2 GRANTED
Friday, October 13, 2017STATEMENT OF USE PROCESSING COMPLETE
Friday, March 24, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 28, 2017SOU TEAS EXTENSION RECEIVED
Thursday, September 28, 2017SOU EXTENSION 3 FILED
Thursday, September 28, 2017SOU EXTENSION 3 GRANTED
Saturday, September 30, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 5, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, October 5, 2017USE AMENDMENT FILED
Thursday, October 12, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 5, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, March 21, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, October 13, 2017SU - NON-FINAL ACTION - WRITTEN
Friday, October 13, 2017NON-FINAL ACTION E-MAILED
Friday, October 13, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 16, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 25, 2017ASSIGNED TO LIE
Friday, October 27, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 27, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 27, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, October 28, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, November 18, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 18, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 18, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, December 5, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, June 21, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

advocate mylan pharmaceuticals properties treatment multiple sclerosis therapeutic prophylactic information patients relating